Specific immunotherapy in atopic eczema;Spezifische hyposensibilisierung bei atopischem ekzem

Allergologie

Volumn 28, Issue 2, 2005, Pages 53-61

  Darsow, U ^a   Forer, I ^a   Ring, J ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Allergy; Atopic dermatitis; Atopic eczema; Hyposensitisation; Specific immunotherapy

Indexed keywords

ALLERGEN; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; PLACEBO;

ATOPIC DERMATITIS; BIOPSY; CLINICAL TRIAL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOTHERAPY; PATCH TEST; REVIEW; T LYMPHOCYTE;

EID: 14844298599     PISSN: 03445062     EISSN: None     Source Type: Journal    
DOI: 10.5414/alp28053     Document Type: Review

References (57)

1. Adinoff A., P. Tellez, R. Clark: Atopic dermatitis and aeroallergen contact sensitivity. J. Allergy Clin. Immunol. 81, 736-742 (1988).
2. Bieber T.: FCeRI on human Langerhans cells: a receptor in search of new functions. Immunol. Today 15, 52-53 (1994).
3. Bieber T., C. de la Salle, A. Wollenberg, J. Hakimi, R. Chizzonite, J. Ring: Constitutive expression of the high affinity receptor for IgE (FCeRl) on human Langerhans cells. J. Exp. Med. 175, 1285-1290 (1992).
4. Bousquet J., R.F. Lockey, H.J. Malling: WHO position paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 53 (Suppl. 44), S1-S42 (1998).
5. Bruijnzeel-Koomen C., D.F. van Wichen, J. Toonstra, L. Berrens, P.L.B. Bruijnzeel: The presence of IgE molecules on epidermal Langerhans cells in patients with atopic dermatitis. Arch. Dermatol, Res. 278, 199-205 (1986).
6. Chait I., V. Allkins: Remission of life-long atopic dermatitis after hyposensitisation to house dust mite. Practitioner 229, 609-612 (1985).
7. Darsow U., H. Behrendt, J. Ring: Gramineae pollen as trigger factors of atopic eczema: evaluation of diagnostic measures using the atopy patch test. Br. J. Dermatol. 137, 201-207 (1997).
8. Darsow U., D. Vieluf, B. Berg, J. Berger, A. Busse, W. Czech, A. Heese, U. Heidelbach, K.P. Peters, B. Przybilla, G. Richter, F. Rueff, T. Werfel, A. Wistokat-Wülfing, J. Ring: Dose response study of atopy patch test in children with atopic eczema. Pediatr. Asthma Allergy Immunol. 13, 115-122 (1999).
9. Darsow U., D. Vieluf, J. Ring for the APT study group: Evaluating the relevance of aeroallergen sensitization in atopic eczema using the tool "atopy patch test": a randomized, double-blind multicenter study. J. Am. Acad. Dermatol. 40, 187-193 (1999).
10. Darsow U., D. Vieluf, J. Ring: Atopy patch test with different vehicles and allergen concentrations - an approach to standardization. J. Allergy Clin. Immunol. 95, 677-684 (1995).
11. Darsow U., D. Vieluf, J. Ring: The atopy patch test: an increased rate of reactivity in patients who have an air-exposed pattern of atopic eczema. Br. J. Dermatol. 135, 182-186 (1996).
12. Di Prisco de Fuenmayor M.C., R.H. Champion: Specific hyposensitization in atopic dermatitis. Br. J. Dermatol. 101, 697-700 (1979).
13. Elliot J.R., M.D. Middleton, E. Charles, M.D. Reed: Allergy: Principles and Practice (4th ed.). Mosby, St. Louis 1993.
14. Fuchs E., H. Schadewaldt: Die Einführung der Hyposensibilisierung in die Heufiebertherapie durch Leonard Noon (1878-1913) und John Freemann (1877-1962) im Jahre 1911. Allergo J. 5, 298-300 (1996).
15. Fukuda H., S. Imayama, T. Okada: Mite-free room (MFR) for the management of atopic dermatitis. Jpn. J. Allergol. 40, 626-632 (1991).
16. Galli E., L. Chini, S. Nardi, N. Benincori, P. Panei, G. Fraioli, V. Moschese, P. Rossi: Use of specific oral hyposensitization therapy to Dermatophagoides pteronyssinus in children with atopic dermatitis. Allergol. Immunopathol. 22, 18-22 (1994).
17. Glover M.T., D.J. Atherton: A double-blind controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with atopic eczema. Clin. Exp. Allergy 22, 440-446 (1992).
18. Gondo A., N. Saeki, Y. Tokuda: Challenge reactions in atopic dermatitis after percutaneous entry of mite antigen. Br. J. Dermatol. 115, 485-493 (1986).
19. Grewe M.: Hyposensibilisierung bei atopischem Ekzem. Allergo J. 9, 351-353 (2000).
20. Hanifin J.M., G. Rajka: Diagnostic features of atopic dermatitis. Acta Derm. Venereol. (Stockh.) 114, 146-148 (1980).
21. Heijer A.: Hyposensitization with aeroallergens in atopic eczema. Allergo J. 2, 3-7 (1993).
22. Karl S., J. Ring: Pro and contra of specific hyposensitization. Eur. J. Dermatol. 9, 325-331 (1999).
23. Kaufman H.S., H.L. Roth: Hyposensitization with alum precipitated extracts in atopic dermatitis: a placebo-controlled study. Ann. Allergy 32, 321-330 (1974).
24. Kühr J., J. Brauburger, S. Zielen, U. Schauer, W. Kamin, A. Von Berg, W. Leupold, K.C. Bergmann, C. Rolinck-Werninghaus, M. Gräve, T. Hultsch, U. Wahn and the Omalizumab Rhinitis Study Group: Efficiacy of combination treatment with anti-lgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis. J. Allergy Clin. Immunol. 109, 274-280 (2002).
25. Lau S., B. Ehnert, B. Cremer, S. Nasert, P. Büttner, B.M. Czarnetzki, U. Wahn: Häusliche Häusliche Milbenaller-genreduktion bei spezifisch sensibilisierten Patienten mit atopischem Ekzem. Allergo J. 4, 432-435 (1995).
26. Leroy B.P., G. Boden, J.M. Lachapelle, M.G. Jacquemin, J.M. Saint-Remy: A novel therapy for atopic dermatitis with allergen-antibody complexes: a double-blind, placebo-controlled study. Am. Acad. Dermatol. 28, 232-239 (1993).
27. Leroy B.P., J.M. Lachapelle, M.M. Somville, M.G. Jacquemin, J.M. Saint-Remy: Injection of allergen-antibody complexes is an effective treatment of atopic dermatitis. Dermatologica 182, 98-106 (1991).
28. Leung D.Y.M., A.R. Rhodes, R.S. Geha, L.C. Schneider, J. J. Ring: Atopic dermatitis (atopic eczema). In: Fitzpatrick T.B., A.Z. Eisen, K. Wolff, I.M. Freedberg, K.F. Austen: Dermatology in general medicine (4th ed.). McGraw Hill, New York 1993, 1543-1563.
29. Maeda K., K. Yamamoto, Y. Tanaka, S. Anan, H. Yoshida: House dust mite (HDM) antigen in naturally occurring lesions of atopic dermatitis (AD): the relationship between HDM antigen in the skin and HDM antigen-specific IgE antibody. J. Derm. Sci. 3, 73-77 (1992).
30. Malling H.J., B. Weeke: Immunotherapy. Position paper of the European Academy of Allergy and Clinical Immunology. Allergy 48 (Suppl. 14), S9-S35 (1993).
31. Mastrandrea F.: Immunotherapy in atopic dermatitis. Exp. Opin. Invest. Drugs 10, 1-15 (2001).
32. Mastrandrea F., G. Serio, M. Minelli: Specific sublingual immunotherapy in atopic dermatitis. Results of a 6-year follow-up of 35 consecutive patients. Allergol. Immunopathol. 28, 54-62 (2000).
33. Maurer D., C. Ebner, B. Reininger, E. Fiebiger, D. Kraft, J.P. Kinet, G. Stingl: The high affinity IgE receptor mediates IgE-dependent allergen presentation. J. Immunol. 154, 6285-6290 (1995).
34. Michils A., C.M. Farber, J.P. Van Vooren, J.C. Yernault, J. Duchateau: Sustained benefit of interferon-alpha therapy and oral hyposensitization in severe atopic dermatitis. Br. J. Dermatol. 130, 134-135 (1994).
35. Mitchell E., M. Chapman, F. Pope, J. Crow, S. Jouhal, T. Platts-Mills: Basophils in allergen-induced patch test sites in atopic dermatitis. Lancet 1, 127-130 (1982).
36. Morren M.A., B. Przybilla, M. Bamelis, B. Heykants, A. Reynaers, H. Degreef: Atopic dermatitis: triggering factors. J. Am. Acad. Dermatol. 31, 467-473 (1994).
37. Mosca M., G. Albani-Rocchetti, M.A. Vignini, S. Ubezio, A.G. Nume, A. Di Silverio: La vaccino-terapia sub-linguale nella dermatite atopica. G. Ital. Dermatol. Venereol. 128, 79-83 (1993).
38. Noh G., K.J. Lee: Pilot study of IFN-gamma-induced specific hyposensitization for house dust mites in atopic dermatitis: IFN-gamma-induced immune deviation as a new therapeutic concept for atopic dermatitis. Cytokine 12, 472-476 (2000).
39. Pacor M.L., D. Biasi, T. Maleknia: The efficacy of long-term specific immunotherapy for Dermatophagoides pteronyssinus in patients with atopic dermatitis. Recenti Prog. Med. 85, 273-277 (1994).
40. Petrova S.I., V.M. Berzhets, V.I. Albanova, T.F. Bystritskaia, N.S. Petrova: Immunotherapy in the complex treatment of patients with atopic dermatitis with sensitization to house dust mites. Zh. Mikrobiol. Epidemiol. Immunobiol. 1, 33-36 (2001).
41. Rajka G.: Essential Aspects of Atopic Dermatitis. Springer, Berlin 1989.
42. Ramb-Lindhauer C.H., A. Feldmann, M. Rotte, C.H. Neumann: Characterization of grass pollen-reactive T cell lines derived from lesional atopic skin. Arch. Dermatol. Res. 283, 71-76 (1991).
43. Ring J.: Angewandte Allergologie, 3. Aufl. MMV Medizin Verlag, München 2004.
44. Ring J.: Successful hyposensitization treatment in atopic eczema: results of a trial in monozygotic twins. Br. J. Dermatol. 107, 597-602 (1982).
45. Ring J.: Spezifische Hyposensibilisierung bei atopischem Ekzem? Allergo J. 2, 1-2 (1993).
46. Ring J., B. Przybilla, J. Bongardts: Safety of hyposensitization. In: Cortada Macias J.M.: Proc. Annual Meeting of the EAACI. Abelló, Madrid 1987, 130-138.
47. Sanda T., T. Yasue, M. Oohashi, A. Yasue: Effectiveness of house dust mite allergen avoidance with atopic dermatitis. J. Allergy Clin. Immunol. 89, 653-657 (1992).
48. Saurat J.H.: Specific hyposensitization for atopic dermatitis: a new era? Dermatologica 182, 71-72 (1991).
49. Seidenari S., M. Mosca, M. Taglietti, S. Manco, G. Nume: Specific hyposensitization in atopic dermatitis. Dermatologica 172, 229 (1986).
50. Tan B., D. Weald, I. Strickland, P. Friedman: Double-blind controlled trial of effect of housedust mite allergen avoidance on atopic dermatitis. Lancet 347, 15-18 (1996).
51. Tanaka Y., S. Anan, H. Yoshida: Immunohistochemical studies in mite antigen-induced patch test sites in atopic dermatitis. J. Derm. Sci. 1, 361-368 (1990).
52. Trofimowicz A., E. Rzepecka, J. Hofman: Clinical effects of specific immunotherapy in children with atopic dermatitis. Rocz. Akad. Med. Bialymst. 40, 414-422 (1995).
53. van Reijsen F.C., C.A.F.M. Bruijnzeel-Koomen, F.S. Kalthoff, E. Maggi, S. Romagnani, J.K.T. Westland, G.C. Mudde: Skin-derived aeroallergen-specific T cell clones of TH2 phenotype in patiens with atopic dermatitis. J. Allergy Clin. Immunol. 90, 184-192 (1992).
54. Warner J.O., J.F. Price, J.F. Soothill, E.N. Hey: Controlled trial of hyposensitisation to Dermatophagoides pteronyssinus in children with asthma. Lancet II, 912-915 (1978).
55. Willemse A., W. van den Brom, A. Rijnberk: Effect of hyposensitization on atopic dermatitis in dogs. J. Am. Vet. Med. Assoc. 184, 1277-1280 (1984).
56. Zachariae H., M. Cramers, T. Herlin, J. Jensen, K. Kragballe, T. Ternowitz, K. Thestrup-Pedersen: Non-specific immunotherapy and specific hyposensitization in severe atopic dermatitis. Acta Derm. Venereol. (Suppl. 114), S48-S54 (1985).
57. Zwacka G., S. Glaser, B. Rieger: Therapeutische Erfahrungen mit Pangramin-SLIT im Vergleich zu einer subkutanen Immuntherapie und zur symptomatischen medikamentösen Behandlung bei Kindern mit Asthma bronchiale, Rhinokonjunktivitis und atopischer Dermatitis. Allergologie 19, 580-592 (1996).